Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Epicore Biosystems
United States
- Cambridge, Massachusetts
- 09/02/2022
- Series A
- $10,000,000
Epicore Biosystems, Inc. has developed a proprietary sweat microfluidic sensing platform that is ‘skin-like’, low-cost, and capable of analyzing small droplets of sweat directly from the skin. This technology is based on over two decades of microfluidic and soft materials research in Prof. John Rogers' Laboratory at Northwestern University's Center for Bio-Integrated Electronics.
Epicore Biosystems recently signed a partnership with a leading Fortune 100 global brand to commercialize the first-ever, single-use sweat analytics system for athletes. The company’s sweat microfluidic platform has been deployed with professional sports teams (NBA, NFL, and MLB), military research labs, and across multiple clinical study programs, including stroke, skin health, stress, fatigue, and kidney health
- Industry Medical Equipment Manufacturing
- Website https://www.epicorebiosystems.com/
- LinkedIn https://www.linkedin.com/company/epicore-biosystems/
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)